Trial Profile
Differential effect of telmisartan and amlodipine on monocyte chemoattractant protein-1 and peroxisome proliferator-activated receptor-gamma gene expression in peripheral monocytes in patients with essential hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Mar 2011
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Telmisartan (Primary)
- Indications Essential hypertension
- Focus Pharmacodynamics
- 23 Mar 2011 New trial record